Article
The MDM2–p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells
2 Apr 2024
Abstract excerpt
The prevention of tumor recurrence by the successful targeting of glioma stem cells endowed with a tumor-initiating capacity is deemed the key to the long-term survival of glioblastoma patients. Glioma stem cells are characterized by their marked therapeutic resistance; however, recent evidence suggests that they have unique vulnerabilities that may be therapeutically targeted. We investigated MDM2 expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
